The academic theatre of shadows: epistemological and ethical erosion in the era of marketing-based medicine Authors: Piotr Bramora, Wiesław Pilis Published: 2026 ABSTRACT This paper analyzes the systemic crisis within contemporary medical academia, characterized by the authors as the “Academic Theatre of Shadows.” This phenomenon occurs when the epistemological rigor of Evidence-Based Medicine (EBM) is superseded by Evidence-Based Marketing (EBM-m). The study examines how modern academic institutions consciously or unconsciously facilitate an environment where charismatic med-influencers prioritize digital metrics, public relations, and commercial viability over physiological accuracy, patient safety, and methodological validation. By deconstructing the mechanism of “commodity diagnostics”—specifically analyzing the misinterpretation of Cross-reactive Carbohydrate Determinants (CCDs) as a prime case study—the article highlights how analytical errors are deliberately rebranded as scientific discoveries. This process creates an ethical hazard by pathologizing healthy populations for commercial gain, transforming citizens into “phantom patients.” Furthermore, the paper explores the sociological “Inversion of Hierarchy,” drawing parallels with the Theranos scandal, to demonstrate how administrative support for marketing-driven agendas marginalizes expert epistemic authority. The article concludes by utilizing the frameworks of agnotology and communicative action to analyze institutional complicity, ultimately advocating for a radical return to epistemic responsibility and the ethical foundations of the university as an uncompromising guardian of scientific truth. Introduction: the epistemological crisis of the contemporary university The classical mission of the university, historically rooted in the Humboldtian ideal of the 19th century, emphasizes the disinterested pursuit of objective truth (Wissenschaft) through the inseparable synergy of research and teaching. Within this traditional framework, epistemic authority was derived from rigorous methodological adherence, skepticism, and robust peer validation. The academic institution served as a sanctuary shielded from the immediate, corrupting pressures of the free market, allowing researchers to pursue physiological and biological realities regardless of their commercial viability. However, in the 21st-century medical and academic landscape, this ideal is increasingly being dismantled and replaced by a corporate-driven, neoliberal model of higher education. Under this new paradigm, the intrinsic value of scientific discovery is frequently subordinated to its market value, fundamentally altering the ontological nature of academic knowledge production. This structural and ideological shift has birthed what can be diagnosed as the “Academic Theatre of Shadows”. Borrowing conceptually from Plato’s classical allegory of the cave—where illusions are mistaken for reality—and Jean Baudrillard’s theory of simulacra—a state where diagnostic signs and labels completely detach from the actual biological reality they were originally meant to represent—this theater represents a profound structural dysfunction. In this contemporary academic cave, representational images, carefully curated social media metrics, and heavily funded marketing narratives are consistently mistaken for clinical reality and immutable biological laws. In this environment, the symbolic prestige and historical credibility of the university are actively weaponized to validate commercially motivated narratives. This is not merely a crisis of professional ethics; it is a profound erosion of epistemic integrity. The boundary between rigorous scientific inquiry and sophisticated public relations becomes deliberately blurred. As profoundly noted by Douglas Altman over two decades ago, much of current medical research is poorly designed and ethically questionable (Altman 1994, p. 283). This pre-existing vulnerability—a latent epistemological rot within the biomedical sciences, characterized by historical methodological laxity, systemic publication bias, and the ongoing replication crisis—has merely created a fertile ground for the current, far more insidious dysfunctions driven by digital marketing algorithms and the attention economy. The result is an environment where the aesthetic appearance of science is valued over the substance of scientific truth. The university transforms from an arbiter of reality into a producer of highly profitable illusions. From evidence-based medicine to evidence-based marketing: the ontology of commodity diagnostics This systemic production of illusions necessitates a new framework for understanding clinical data. Consequently, the transition from Evidence-Based Medicine (EBM) to Evidence-Based Marketing (EBM-m) represents a fundamental ontological and epistemological shift within medical academia (Spielmans and Parry 2010). The original principles of EBM did not emerge monolithically; rather, they were forged in a rigorous epistemological battleground during the second half of the 20th century. Pioneers such as Alvan Feinstein, Archie Cochrane, and later David Sackett and the Oxford School, fiercely debated the very nature of medical evidence and the hierarchy of clinical authority. Despite these internal complexities, the early foundation of EBM was painstakingly designed to minimize cognitive and financial bias, eliminate systematic error, and ground clinical practice in rigorous, peer-reviewed empirical data (Sackett et al. 1996, p. 71). EBM functioned as an epistemic safeguard, dictating that the “evidence” must precede and shape the clinical narrative. Conversely, EBM-m operates on a reversed timeline: the marketing narrative is established first, and the “evidence” is subsequently curated, manipulated, or entirely fabricated to support the commercial objective. EBM-m instrumentalizes the aesthetic and rhetorical appearance of science solely to maximize market reach and profitability. This paradigm shift leads directly to what has been termed “the illusion of evidence” (Jureidini and McHenry 2020), where heavily funded marketing campaigns—often masquerading as independent clinical guidelines, diagnostic innovations, or academic breakthroughs—dictate clinical perceptions rather than underlying physiological facts. Here, medicine enters the realm of Baudrillard’s simulacrum: the diagnostic label (the signifier) detaches completely from the actual biological pathology (the signified). A critical, tangible manifestation of this crisis is found in the phenomenon of “commodity diagnostics”. In a traditional, robust scientific framework, an analytical interference, a cross-reaction, or a false-positive result in a laboratory test is immediately recognized as a technical failure—a flaw requiring immediate methodological correction, recalibration, and academic transparency. However, within the “Theatre of Shadows,” these very analytical errors are effectively rebranded as “innovative breakthroughs” or utilized as indicators of newly discovered, highly prevalent hidden pathologies. To fully grasp the mechanics of commodity diagnostics, one must examine specific biochemical examples, such as the contemporary abuse of multiplex allergy testing and the role of Cross-reactive Carbohydrate Determinants (CCDs). CCDs are ubiquitous carbohydrate structures present on many plant and invertebrate proteins. In human serology, they frequently stimulate the production of specific IgE antibodies. However, these anti-CCD IgE antibodies generally possess minimal to no clinical relevance; they do not cause actual allergic reactions or anaphylaxis in patients. In a scientifically rigorous diagnostic process, the interference caused by CCDs must be actively inhibited or analytically excluded to prevent massive false-positive results across dozens of tested allergens (Holzweber et al. 2014, p. 7642). Yet, under the regime of EBM-m, this fundamental biochemical limitation is frequently ignored or intentionally obscured by commercially-aligned med-influencers and private diagnostic laboratories operating under the implicit endorsement of academic institutions. By omitting the vital context of CCD cross-reactivity, these actors present healthy individuals with extensive lists of “positive” allergies (ranging from peanuts to wheat and pollens) based purely on in vitro artifacts. Thus, an analytical error is weaponized into a diagnostic commodity. This commodification of diagnosis systematically produces “phantom patients”. These are entirely healthy individuals who, through fundamentally flawed diagnostics promoted by figures wielding academic authority, become deeply convinced of suffering from complex, chronic, or severe conditions. This systemic manufacturing of illness guarantees a constant, lucrative demand for unvalidated diagnostic monitoring, restrictive dietary regimens, bespoke supplements, and specialized medical consultations. It perfectly illustrates the unethical capitalization of induced health anxiety, where the university’s epistemological failure directly translates into a highly profitable business model for the private sector. It is crucial to note that this commodification of diagnostics manifests differently depending on the macro-structure of the healthcare system. In highly commercialized, market-driven models like the United States, EBM-m operates overtly through direct-to-consumer advertising and privatized diagnostic centers. Conversely, within European welfare state systems, this epistemic erosion is often more subtle, mediated through bureaucratic standardization, where administrative guidelines unwittingly adopt commercially driven metrics as indicators of public health efficiency. To further contextualize the phenomenon of the “phantom patient,” this process must be analyzed through the theoretical framework of Michel Foucault’s biopolitics—the strategy by which human life, biology, and population health are managed, quantified, and controlled by institutional power—and the medical gaze (le regard médical). Historically, as Foucault outlined in The Birth of the Clinic, the clinical gaze objectified the patient’s body to identify and isolate a localized, pre-existing physical disease (Foucault 1973). The traditional university hospital was the institutional locus of this diagnostic gaze. However, in the era of Evidence-Based Marketing and commodity diagnostics, this gaze has mutated fundamentally. It is no longer an investigative gaze searching for existing pathology; it has become a speculative, algorithmic gaze that proactively constructs potential pathology to expand the medical market. The phantom patient thus becomes a prime subject of contemporary biopower. Their very conception of wellness, somatic normality, and physiological baseline is completely dictated by the commercial imperatives of the academic med-influencer. The university, by participating in this, shifts its role from therapeutic intervention to the “anticipatory commodification” of the healthy body. By convincing healthy populations that their normal physiological variations (such as clinically irrelevant CCD cross-reactivity) are in fact dangerous, hidden pathologies requiring continuous surveillance, EBM-m extends medical control over everyday life. This is the ultimate triumph of biopolitics: the patient actively and anxiously monitors their own artificially constructed disease, eagerly funding their own subjugation to the marketing narrative. To further understand the epistemological danger of Evidence-Based Marketing, we must view it through the lens of Karl Popper’s demarcation problem and Harry Frankfurt’s philosophical analysis of truth. The narratives constructed by academic med-influencers surrounding commodity diagnostics frequently operate intentionally outside the boundaries of falsifiability (Popper 1959). When a healthy patient is diagnosed with an artificial pathology via misinterpreted CCDs, the clinical narrative is structured to be irrefutable from the patient’s perspective. Any subsequent lack of physical symptoms is attributed to the “success” of the influencer’s restrictive diet or supplement regime, while any occurrence of normal physiological discomfort is claimed as “proof” of the underlying hidden disease. This creates a closed, self-sealing epistemological loop that mimics science but operates as dogma. Furthermore, EBM-m epitomizes what philosopher Harry Frankfurt famously defined as “bullshit”—a specific mode of communication where the speaker is not explicitly lying, but is simply indifferent to the truth-value of their statements (Frankfurt 2005). The med-influencer is primarily concerned with persuasion, algorithmic engagement, and market conversion. By treating the actual physiological truth as irrelevant to the marketing objective, EBM-m inflicts a much deeper and more insidious wound on academic integrity than mere scientific error. The inversion of hierarchy: charismatic power versus epistemic authority The perpetuation of this highly profitable business model within the academy cannot occur organically; it is structurally sustained by a profound sociological and epistemological phenomenon: the Inverted Hierarchy. To fully understand the danger of this inversion, one must return to classical philosophical and sociological distinctions of authority. Józef Maria Bocheński, in his seminal analyses, clearly delineates “epistemic authority” (the authority of the one who knows, based on verifiable expertise) from “deontic authority” (the authority of the one who commands or influences) (Bocheński 1974). Historically, the university’s internal hierarchy was almost exclusively founded upon epistemic authority. Prestige, tenure, and decision-making power were directly proportional to the depth of a scholar’s understanding of biological limitations, their strict adherence to methodological rigor, and their critical peer-reviewed output. In the current academic landscape, however, we are witnessing a systemic usurpation of epistemic authority by what can be termed “media authority”. Media authority is not measured by scientific validity, reproducibility, or theoretical coherence; rather, it is quantified by digital engagement, follower counts, algorithmic visibility, and the ability to generate rapid institutional public relations. This dynamic can be understood through the lens of Max Weber’s tripartite classification of authority. The traditional, rational-legal authority of the scientific method is being rapidly displaced by a modern, digital iteration of “charismatic authority” (Weber 1978). The modern academic med-influencer, wielding this charismatic power, relies on emotional resonance, fear-mongering regarding “hidden” diseases, and rhetorical simplification, systematically bypassing complex physiological truths. When university administrations capitulate to this media authority, the Inverted Hierarchy is complete. We are experiencing what Jerry Z. Muller terms “the tyranny of metrics,” where easily quantifiable digital interactions—likes, shares, media appearances, and commercial sponsorships—entirely replace qualitative judgments of scientific worth and ethical integrity (Muller 2018). The genuine expert—the clinical physiologist, the critical biochemist, or the senior researcher—who raises valid methodological concerns about commodity diagnostics is increasingly marginalized. Within the corporatized academic structure, these true epistemic authorities are often stigmatized by administrators as “obstructive,” “inflexible,” or detrimental to the university’s dynamic modern image (White 2019). Crucially, the triumph of media authority over epistemic authority is not merely a psychological failing or an ethical lapse on the part of university administrators; it is a structural inevitability dictated by the architecture of platform capitalism. Drawing on Shoshana Zuboff’s critique of surveillance capitalism, we must recognize that the digital platforms enabling med-influencers are ontologically indifferent to scientific truth (Zuboff 2019). The algorithms governing these platforms are optimized exclusively for user engagement—specifically, emotional arousal, outrage, and fear. Consequently, complex, nuanced, and highly contextualized EBM narratives (such as the intricate biochemical explanations required to understand analytical interference) are algorithmically suppressed because they demand cognitive effort and do not trigger rapid emotional responses. Conversely, the simplified, fear-based narratives of commodity diagnostics (e.g., alarming claims about “hidden allergies destroying your immune system”) are algorithmically amplified. When a medical university aligns its internal criteria for success and prestige with these external algorithmic metrics, it essentially outsources its epistemological standards to private technology corporations. The institution ceases to evaluate how true a biological claim is, and instead evaluates how far the claim can travel across digital networks. This algorithmic determinism guarantees that charismatic power will always defeat methodical epistemic authority in the digital public square, unless the university actively builds structural firewalls against these metrics. The devastating potential of this unchecked charismatic authority within biomedical science is perfectly exemplified by the Theranos scandal, which serves as the ultimate paradigm of this structural failure. Elizabeth Holmes did not build a multi-billion-dollar medical empire on peer-reviewed validation, reproducible data, or rigorous epistemic authority. Instead, she bypassed the traditional scientific community entirely, leveraging charismatic narratives, aggressive media compliance, and the uncritical backing of powerful institutional elites to mask profound technological and biological failures (Jeske 2020, p. 323). The Theranos case highlights how a compelling marketing story can entirely blind highly educated individuals to physiological impossibilities. When contemporary medical universities adopt these exact same mechanisms—elevating the digital influencer over the methodical scientist and protecting commercial diagnostic ventures from internal critique—they actively dismantle their own ethical safeguards. By institutionalizing the Inverted Hierarchy, the university leaves both the academic community and the general public entirely defenseless against the medical and psychological harms of Marketing-Based Medicine. Institutional responsibility and the agnotology of silence The “Academic Theatre of Shadows” and its inverted hierarchy cannot function without a stage consciously provided by university administrations. The institutional apparatus is not merely a passive backdrop to the epistemic erosion described above; it is an active facilitator. When institutional leadership faces overwhelming systemic pressure to prioritize brand visibility, media metrics, and lucrative commercial partnerships over scientific accuracy and public health, it risks facilitating a fundamental betrayal of public trust. This is often not a conscious, universal failing of individual administrators—many of whom strive to maintain robust ethical oversight in difficult environments—but rather a profound structural vulnerability where the foundational telos of the university—truth-seeking—is subordinated to the logic of market capitalism. To understand the philosophical gravity of this transition, it must be analyzed through the lens of agnotology—the study of culturally induced ignorance or doubt, particularly regarding scientifically proven data. As articulated by Robert Proctor, ignorance is not always a natural void or a simple absence of knowledge; it is frequently a constructed entity, actively engineered and maintained by powerful interest groups to protect commercial assets (Michaels 2008; Proctor and Schiebinger 2008, p. 8). In the era of Evidence-Based Marketing, the university administration unwittingly (or sometimes deliberately) becomes a central node in this agnotological network. The institutional validation of med-influencers and the uncritical acceptance of commodity diagnostics serve to manufacture epistemic confusion. By allowing academic titles to be used in the promotion of fundamentally flawed diagnostic paradigms (such as the uninhibited CCD testing), the university actively participates in the production of ignorance. The use of historical university prestige to shield these marketing-driven agendas creates a powerful “protective umbrella” that simultaneously legitimizes false narratives and actively stifles internal academic criticism. This dynamic enforces what can be termed the “Ethics of Silence” within the academic community. The “protective umbrella” rewards the continuous production of pseudepisteme (false knowledge masquerading as scientific fact) while structurally disempowering those who attempt to expose it. Junior researchers and critical clinicians quickly observe that challenging the highly lucrative narratives of academic influencers carries significant professional risk, leading to pervasive self-censorship. When the institution punishes epistemic whistleblowing to protect its market position, it destroys the very mechanism of self-correction that separates science from dogma. The resulting silence is not merely an absence of speech; it is a complicit act that allows the “Theatre of Shadows” to pathologize the public uninterrupted. The institutional enforcement of this Ethics of Silence produces a secondary, highly toxic effect within the academic community: moral injury. Originally conceptualized in military psychology, moral injury occurs when individuals are forced to participate in, or are rendered powerless to prevent, actions that severely transgress their deeply held moral and professional beliefs (Shay 2014). For dedicated scientists, clinical physiologists, and ethically grounded researchers working within these corporatized institutions, witnessing the university’s administrative apparatus actively promote and protect the creators of pseudepisteme is profoundly traumatizing. They are trapped in a systemic double bind: they possess the genuine epistemic authority and methodological expertise to debunk the dangerous narratives of commodity diagnostics, yet they are structurally paralyzed by the imminent threat of professional retaliation from university leadership. This chronic exposure to institutional betrayal leads to profound disillusionment, severe burnout, and ultimately, the silent exodus of genuine scientific talent from the academy. By alienating its most ethically grounded scholars to protect its market-driven influencers, the university accelerates its own transformation into a hollow shell of public relations. Bioethical implications: the harm of the “Phantom Patient” The epistemological failures and agnotological practices detailed above inevitably cascade into severe ethical violations. The core principles of modern bioethics—specifically non-maleficence (do no harm) and respect for autonomy—are fundamentally compromised within the Academic Theatre of Shadows. Marketing-Based Medicine, driven by commodity diagnostics, inherently violates the principle of non-maleficence. The creation of the “phantom patient” is not a benign phenomenon. When a healthy individual is incorrectly diagnosed with multiple severe allergies or chronic systemic conditions due to the deliberate misinterpretation of in vitro analytical errors, they suffer profound psychological harm. This medically induced health anxiety (iatrogenic harm) dramatically reduces their quality of life. Furthermore, these patients are often subjected to unnecessary, restrictive diets that can lead to actual physical malnutrition, alongside the financial toxicity of purchasing unvalidated treatments, supplements, and endless follow-up consultations. Autonomy is equally compromised. True patient autonomy requires informed consent, which is predicated on the patient receiving accurate, truthful, and scientifically valid information. When the information provided is systematically distorted by EBM-m narratives—when the “evidence” is merely an illusion crafted for market reach (Jureidini and McHenry 2020)—the patient’s ability to make a rational, informed decision about their own body is entirely subverted. The university, by lending its epistemic authority to these marketing narratives, becomes directly complicit in the bioethical violation of the public it is meant to serve. The profound bioethical harm of the “phantom patient” phenomenon can be further illuminated by Jürgen Habermas’s sociological concept of the “colonization of the lifeworld” (Kolonialisierung der Lebenswelt)—a process where the intimate, communicative, and narrative aspects of human life are overtaken by the cold, instrumental, and bureaucratic logic of systems like the free market (Habermas 1984). In this context, the “lifeworld” represents the patient’s subjective, lived experience of their own body, naturally characterized by organic meaning and communicative rationality. Conversely, the “system” represents the instrumental, heavily commodified, profit-driven logic of the medical marketplace. In the Academic Theatre of Shadows, the university effectively acts as a Trojan horse, allowing the relentless imperatives of the system to aggressively invade and colonize the patient’s intimate lifeworld. When a med-influencer pathologizes normal, everyday somatic experiences using the illegitimate weight of academic authority, they force the patient to reinterpret their own body not as a lived, resilient organism, but as a failing biochemical machine requiring constant, expensive commercial maintenance. The patient’s natural relationship with their health is systematically replaced by an anxious, instrumental, and transactional relationship with the influencer’s brand. This colonization deprives individuals of their somatic autonomy and fundamentally alienates them from their own physical existence, representing a profound moral failing of the medical institutions that facilitate it. Furthermore, the bioethical violation extends beyond physical and financial harm into the realm of epistemic exploitation. Building on Miranda Fricker’s conceptualization of epistemic injustice, we can observe that the phantom patient is frequently subjected to a sophisticated form of hermeneutical injustice (Fricker 2007, p. 147). Patients experiencing vague, everyday somatic symptoms—such as standard fatigue or mild gastrointestinal discomfort—seek meaning and explanation from medical authorities. In the Theatre of Shadows, they are provided with a scientifically hollow vocabulary (a set of rebranded analytical errors presented as diagnostic labels) that falsely helps them make sense of their experiences. Because this deceptive vocabulary carries the authoritative stamp of a university professor or a prestigious medical faculty, the patient adopts it with absolute trust. The institution and the med-influencer thereby engage in epistemic exploitation: they extract financial capital, data, and social media engagement from the patient’s vulnerability and induced anxiety, while depriving the patient of the actual truth regarding their health. The patient’s capacity to understand their own body is colonized by the marketing narrative, representing a profound betrayal of the bioethical mandate to protect vulnerable populations from deception. Conclusion: toward an epistemic and ethical restoration The resolution of the profound crisis within contemporary medical academia requires far more than superficial administrative compliance or updated conflict-of-interest forms; it necessitates a radical, structural return to the Ethics of Evidence. To dismantle the “Academic Theatre of Shadows,” institutions must fundamentally re-evaluate their core operational philosophy and unconditionally embrace the concept of “epistemic responsibility.” As articulated by epistemologist Lorraine Code, epistemic responsibility dictates that knowers—and by extension, knowledge-producing institutions—have a profound moral duty to ensure their claims are grounded in rigorous evidence rather than convenience, ego, or external financial incentives (Code 1987). Currently, by allowing the commodification of diagnostics and the elevation of media authority, universities are failing in this duty, contributing instead to a systemic “epistemic injustice” (Fricker 2007) where the public is systematically misled about the nature of health and pathology. This ethical restoration demands several concrete, non-negotiable paradigm shifts: Implementing Institutional Firewalls and Open Data Mandates: Universities must enforce strict policies requiring all institutional researchers to provide completely open, unredacted access to raw clinical data, preventing the selective curation of results by commercial sponsors. Furthermore, independent epistemological audit committees must be established to review the clinical validity of heavily marketed diagnostic tools before academic endorsement is permitted. Decoupling of Authority and Commerce: There must be a definitive and transparent decoupling of academic affiliations from private, direct-to-consumer commercial diagnostic ventures. This requires structural administrative barriers banning the use of university branding in the promotion of medical products that have not undergone rigorous internal validation. Dismantling the Inverted Hierarchy: Institutional leadership must restructure academic incentives to explicitly reward methodological rigor, critical peer review, and the courage to debunk pseudepisteme, while actively penalizing the weaponization of academic titles for commercial influencer marketing. Promotion and tenure committees must explicitly devalue digital engagement metrics (follower counts, media impact) in their evaluations. Reclaiming the Humboldtian Ideal: We must return to a framework where the trust in science is predicated on the rigorous, critical consensus of a community of genuine experts, not on the charismatic appeal of isolated individuals navigating digital algorithms (Oreskes 2019). Ultimately, the restoration of medical academia requires a reaffirmation of a fundamental ontological boundary: biological facts cannot be altered by social media consensus, nor can physiological limitations be suspended by marketing algorithms. Epistemic accountability must be restored to ensure that the university reclaims its historical telos. It must stand as a resilient sanctuary for objective truth, rigorous methodological skepticism, and patient-centered clinical reality, rather than remaining a passive, complicit stage for shadows.